Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1517 in Hemodialysis-dependent CKD Anemia
NCT01888445Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roxadustat in anemia of chronic kidney disease, sponsored by Astellas Pharma. Started Mar 2013; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT01888445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888445.